Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;25(6):1240-1246.
doi: 10.1016/j.bbmt.2019.02.003. Epub 2019 Feb 11.

Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health

Affiliations

Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health

Colleen M Morken et al. Biol Blood Marrow Transplant. 2019 Jun.

Abstract

The long-term care of hematopoietic stem cell transplantation (HSCT) survivors poses special challenges owing to a myriad of possible chronic and/or late complications. Survivorship care plans (SCPs) have been proposed as tools to communicate information on the late effects of treatment and recommended follow-up care to clinicians and survivors. The primary aims of this study were to determine SCP content and format, as well as to assess the preferred timing of SCP provision following HSCT. HSCT survivors and nontransplantation clinicians (oncologists and primary care physicians) were invited to participate in a survey evaluating the usefulness and utility of a sample HSCT-specific SCP with a treatment summary generated by autopopulation from an electronic health record (EHR). All participating HSCT survivors (n = 29) and clinicians (n = 18) indicated a desire to receive an SCP. More than 85% of the participants perceived information about treatments received, recommended follow-up and health maintenance including vaccinations, survivor and clinician resources, and graft-versus-host disease and other late/chronic side effects to be useful. The majority of survivors also believed that care team contact information was useful. In addition, >85% of survivors and clinicians agreed that the SCP increased their understanding of treatments and chronic/late side effects, improved health care provided, and were satisfied with the SCP and found it understandable and easy to use. The majority of survivors indicated that additional information should be added to the SCP, whereas some clinicians deemed the SCP too long. Survivors preferred to receive the SCP as a paper document at the end of a regular follow-up visit and review it with a cancer clinician, whereas clinicians preferred to receive the SCP through the EHR. These findings will help improve the design of future SCPs for use by HSCT survivors and clinicians. Future work will include leveraging the EHR to ease the burden of creating user-centered documents.

Keywords: Clinician satisfaction; Hematopoietic stem cell transplantation; Survivor satisfaction; Survivorship care plan.

PubMed Disclaimer

Conflict of interest statement

Conflicts/Disclosures:

1. Morken, Colleen M –none

2. Tevaarwerk, Amye J – Epic Systems (family member)

3. Swiecichowski, Amanda K –none

4. Haine, James F –none

5. Williams, Zachary T –none

6. Norslien, Kirsten –none

7. Arroyo, Natalia –none

8. Zhang, Xiao –none

9. Campbell, Bethaney –none

10. Mendonca, Eneida A –none

11. Juckett, Mark B –none

12. Sesto, Mary E –none

Figures

Figure1.
Figure1.
Usefulness of SCP content. On the x-axis: 1, very useful; 2, somewhat useful; 3, neutral; 4, not very useful; 5, not at all useful; 6, don’t include. *Missing 1 response (n = 26). UWCCC, University of Wisconsin Carbone Cancer Center.
Figure2.
Figure2.
SCP utility and satisfaction. On the x-axis: 1, strongly agree; 2, agree; 3, neither agree nor disagree; 4, disagree; 5, strongly disagree; 6, no opinion. *Missing 1 response (n = 26).

Similar articles

Cited by

References

    1. Majhail NS, Tao L, Bredeson C, et al. Prevalence of Hematopoietic Cell Transplant Survivors in the United States. Biology of Blood and Marrow Transplantation. 2013;19(10):1498–1501. - PMC - PubMed
    1. Bevans M, El-Jawahri A, Tierney DK, et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017;23(4):538–551. - PMC - PubMed
    1. Garnett C, Apperley JF, Pavlu J. Treatment and management of graft-versus-host disease: improving response and survival. Therapeutic advances in hematology. 2013;4(6):366–378. - PMC - PubMed
    1. Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood. 2011;118(17):4723–4731. - PMC - PubMed
    1. Sun CL, Francisco L, Kawashima T, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood. 2010;116(17):3129–3139; quiz 3377. - PMC - PubMed

Publication types